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ABSTRACT:
Introduction Smoke- free enclosed public environments 
are effective in reducing exposure to secondhand smoke 
and yield major public health benefits. Building on this, 
many countries are now implementing smoke- free policies 
regulating smoking beyond enclosed public places and 
workplaces. In order to successfully implement such ‘novel 
smoke- free policies’, public support is essential. We aim 
to provide the first comprehensive systematic review and 
meta- analysis assessing levels and determinants of public 
support for novel smoke- free policies.
Methods and analysis The primary objective of this 
review is to summarise the level of public support for novel 
smoke- free policies. Eight online databases ( Embase. 
com, Medline ALL Ovid, Web of Science Core Collection, 
WHO Library Database, Latin American and Caribbean 
Health Sciences Literature, Scientific Online Library Online, 
PsychINFO and Google Scholar) will be searched from 1 
January 2004 by two independent researchers with no 
language restrictions. The initial search was performed 
on 15 April 2020 and will be updated prior to finalisation 
of the report. Studies are eligible if assessing support for 
novel smoke- free policies in the general population (age 
≥16 years) and have a sample size of n≥400. Studies 
funded by the tobacco industry or evaluating support 
among groups with vested interest are excluded. The 
primary outcome is proportion of public support for 
smoke- free policies, subdivided according to the spaces 
covered: (1) indoor private spaces (eg, cars) (2) indoor 
semiprivate spaces (eg, multi- unit housing) (3) outdoor 
(semi)private spaces (eg, courtyards) (4) non- hospitality 
outdoor public spaces (eg, parks, hospital grounds, 
playgrounds) and (5) hospitality outdoor public spaces (eg, 
restaurant terraces). The secondary objective is to identify 
determinants associated with public support on three 
levels: (1) within- study determinants (eg, smoking status) 
(2) between- study determinants (eg, survey year) and (3) 
context- specific determinants (eg, social norms). Risk of 
bias will be assessed using the Mixed Methods Appraisal 
Tool and a sensitivity analysis will be performed excluding 
studies at high risk of bias.
Ethics and dissemination No formal ethical approval 
is required. Findings will be disseminated to academics, 
policymakers and the general public.
INTRODUCTION
Secondhand smoke (SHS) exposure is related 
to 1.2 million deaths per year.1 Smoke- free 
environments have proven to be effective in 
reducing exposure to SHS and have major 
public health benefits.2 Previous systematic 
reviews reported consistent evidence for 
improved cardiovascular health and reduced 
smoking- related mortality, as well as reduc-
tions in preterm birth, severe asthma exac-
erbations and respiratory tract infections 
in children, following implementation of 
smoke- free legislation in indoor public places 
and workplaces.3–5 It has been shown that 
outdoor areas contribute significantly to SHS 
exposure, therefore the implementation of 
smoke- free policies in open spaces has the 
potential to reduce the associated burden of 
disease.6 7
In 2004, Ireland was the first country in the 
world to implement comprehensive smoke- 
free legislation covering enclosed workplaces 
and public places, and many more countries 
followed its example.8 An increasing number 
Strengths and limitations of this study
 ► This systematic review is unique in providing a 
structured overview of levels of public support for 
‘novel smoke- free policies’ (ie, smoke- free policies 
that go beyond regulating smoking in enclosed pub-
lic places and workplaces).
 ► Within- study and between- study determinants as-
sociated with public support will be assessed, and 
thematic synthesis will be used to identify context- 
specific determinants.
 ► The protocol presented has been designed in line 
with the Preferred Reporting Items for Systematic 
Reviews and Meta- Analysis Protocols.
 ► The generalisability and value of this systematic re-
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of jurisdictions is now implementing, or considering 
implementing, additional smoke- free policies that go 
beyond regulating smoking in enclosed public places and 
target private and outdoor spaces, henceforth referred to 
as ‘novel smoke- free policies’. Novel smoke- free policies 
are implemented in an attempt to further improve popu-
lation health via reducing SHS exposure. For example, 
several countries have implemented laws requiring 
private cars carrying children be smoke- free,9–11 smoke- 
free hospital campuses have been implemented country- 
wide in Spain and Ireland,12 13 the city of New York banned 
smoking in all public parks, pedestrian plazas and at all 
beaches,14 and the US Department of Public Housing 
and Urban Development requires all public housing 
units to be smoke- free, both within resident units and 
in public areas.15 Public support is essential in democra-
cies in order for policymakers to consider implementing 
such novel smoke- free policies and to increase the like-
lihood of successful implementation,16 and accordingly 
the WHO stated that ‘Involving civil society is central to 
achieving effective legislation’.5
However, public support may vary over time, as well as 
by population subgroups. For example, women and non- 
smokers tend to be more in favour of smoke- free legis-
lation than men and current smokers.17 Several studies 
showed that public support for smoke- free policies 
increased after successful implementation and particu-
larly so among smokers.18–20 Furthermore, public support 
for smoke- free policies was higher when policies covered 
spaces that were frequently visited by those more vulner-
able to the adverse health effects of SHS.21 For example, 
in the USA and Canada public support for smoke- free 
playgrounds (89%–91%) was substantially higher than 
for smoke- free outdoor workplaces (12%–46%) and side-
walks (31%–49%).17 Context- specific determinants may 
also contribute to differences in public support across 
settings. Aspects that enhanced successful adoption of 
smoke- free zones at outdoor school grounds at secondary 
schools included communication about the policy, collab-
oration between and within stakeholders, social norms 
and evidence about the effectiveness of smoke- free 
zones.22
A structured overview of the levels and determinants of 
public support for smoke- free policies beyond enclosed 
public places and workplaces across various settings is 
currently lacking. Having these insights may guide poli-
cymakers with the implementation of policies that receive 
the highest levels of support, and may help in defining 
additional strategies that are needed to increase public 
support in the population. To address this gap in the liter-
ature, our primary objective is to summarise the level of 
public support across the globe for novel smoke- free poli-
cies and to evaluate if public support changed following 
implementation of the novel smoke- free policies across 
various settings. To do so, a systematic review and meta- 
analysis will be conducted. The secondary objective is to 
identify determinants associated with public support at 
the following three levels: (1) within- study determinants 
(eg, age, smoking status, parental status), (2) between- 
study determinants (eg, income level of the country, 
whether smoke- free legislation in enclosed public places 
and workplaces was already in place) and (3) context- 
specific determinants (eg, setting, framing, enforcement 
of smoke- free policies).
METHODS AND ANALYSIS
We used the Preferred Reporting Items for Systematic 
Reviews and Meta- Analysis Protocols guidelines to facil-
itate development of this protocol, see online supple-
mental appendix 1.
In this review, we will use the term ‘traditional smoke- 
free legislation’ to refer to smoke- free legislation covering 
enclosed public places and workplaces (ie, compliant with 
Article 8 (2) of the Framework Convention on Tobacco 
Control) and the term ‘novel smoke- free policies’ to 
refer to policies and legislation regulating smoking in any 
other places, such as (semi)private places and (partially) 
outdoor spaces, whether public or (semi)private.23 Poli-
cies are used in the broadest sense and are not neces-
sarily enacted via formal legislation as this will allow us to 
evaluate less formal local smoke- free initiatives (eg, self- 
regulation by the hospitality sector or local hospitals) as 
well as formal legislation.
Eligibility criteria
We will include articles published in scientific journals 
as well as ‘grey literature’ evaluating public support for 
novel smoke- free policies covering (semi)private places 
and (partially) outdoor spaces, whether public or (semi)
private. Grey literature includes policy documents and 
reports that are published non- commercially and/or 
are not indexed by major scientific literature databases. 
Cohort studies and (repeated) cross- sectional studies will 
be included and no language restrictions are applied. 
Qualitative studies will be excluded. We will seek transla-
tion for reports in foreign languages to assess eligibility. 
Studies for which only an abstract is available will not be 
included since risk of bias for these studies cannot be 
adequately assessed.
Eligibility of the studies will be assessed using the 
following criteria:
1. Studies will be eligible if support for one or more novel 
smoke- free policies is evaluated. We will include studies 
assessing support for novel smoke- free policies that are 
already in place as well as those assessing support for 
upcoming or theoretical implementation of such poli-
cies. Policies at any level are eligible, such as city- level, 
state- level and country- level. Studies will be excluded 
if solely evaluating traditional smoke- free legislation.23
2. Studies will be eligible if they assessed public support 
for smoke- free policies in the population aged 16 years 
or above who represent the majority of a population 
primarily affected by the policy (eg, support for a 
country- wide measure is evaluated in a representative 
















pen: first published as 10.1136/bm





3Boderie NW, et al. BMJ Open 2021;11:e040167. doi:10.1136/bmjopen-2020-040167
Open access
local campus is assessed among students and staff of 
that specific campus), or in any of the predefined pop-
ulation subgroups (see within- study determinants of pub-
lic support below). We set this age criterion to include 
the part of the population that is entitled to vote in 
most democracies, and as such may be regarded to be 
of particular interest to politicians and policymakers. 
Any study reporting (sub)populations in which at least 
50% fits this age criterion will also be included.
3. Our primary objective is to summarise the level of pub-
lic support for novel smoke- free policies in the general 
population, therefore we will only include studies of 
which we can be confident that the reported support 
in the study sample reflects the levels of support that 
would be found if the entire population was surveyed. 
This is operationalised by only including studies that 
can ensure a 5% margin of error. Following sample 
size calculations for surveys, 24 25 a minimum sample 
size of 400 is required. A similar criterion was used by 
an earlier review assessing public support for outdoor 
smoke- free areas.17
4. Studies will be included when published from 1 Jan-
uary 2004 onwards. This pragmatic cut- off chosen as 
the first national traditional smoke- free law covering 
indoor public places and workplaces was introduced in 
Ireland in 2004. Hence, assessments of public support 
for novel smoke- free policies are unlikely to have pre-
ceded 2004, and are unlikely to be relevant for current 
everyday practice if they have.
5. Studies will be excluded if solely evaluating support 
among specific subgroups not representing the major-
ity of the population primarily affected by the policy, 
policymakers or groups with clearly vested interest, for 
example, opinion of tobacco industry groups.
6. Studies will be excluded when funded or supported by 
the tobacco industry, as the tobacco industry is known 
to ‘produce, sponsor and disseminate misleading re-
search and information, lacking sound scientific meth-
ods’.26
7. Studies will be excluded if solely evaluating support for 
tobacco- related subgroups, for example, e- cigarettes 
or heatless tobacco products.
Information sources
The following electronic databases will be searched for 
eligible studies: (1)  Embase. com, (2) Medline ALL Ovid, 
(3) Web of Science Core Collection, (4) WHO Library 
Database, (5) Latin American and Caribbean Health 
Sciences Literature, (6) Scientific Online Library Online, 
(7) PsychINFO and (8) Google Scholar.
Search strategy
The specific search strategies per database have been 
created in close collaboration with a bibliographical 
expert of the Erasmus MC with expertise in systematic 
reviewing (WMB; see online supplemental appendix 
1). Search terms include three parts: (1) terms to iden-
tify smoke- free policies; (2) terms to identify measures 
of public support as the outcome; and (3) terms that 
exclude letters to the editors, notes and editorials.
We will complement our search by screening reference 
lists of reviews related to the topic and of included studies 
and their citations through Scopus, following Bramer.27 
We will update our search to add the most recent 




All records identified by the search strategy will be 
extracted into an EndNote Library, and we will de- dupli-
cate using this software following the procedure outlined 
by Bramer et al.28 If any duplicates remain, those will be 
manually excluded. At this stage, duplicates will be iden-
tified based on overlapping author names and titles. The 
total number of detected duplicates will be noted in the 
final report.
Selection process
After removing duplicates, titles and abstracts of records 
identified during the literature search will be screened 
independently for inclusion by two reviewers. After initial 
selection based on screening of titles and abstracts, full- 
text articles will be screened for eligibility according to 
the inclusion and exclusion criteria by two reviewers, and 
discrepancies will be resolved after discussion with a third 
reviewer. Remaining duplicates based on populations, 
sample size and reported outcomes will be identified 
based on full text. The reviewers will not be blinded to 
information about the articles (eg, authors’ names and 
affiliations) at any stage.
Data collection process
Two reviewers will independently extract relevant data 
from all included studies according to a customised data 
extraction form developed a priori that was piloted using 
four eligible studies. On completion the reviewers will 
compare their results and any discrepancies will again be 
resolved after discussion with a third reviewer. If any rele-
vant data are missing, the corresponding authors will be 
contacted.
Data items
Customised data extraction forms will be used to extract 
relevant information from the eligible studies, which will 
include the following items:
1. First author’s name and affiliation.
2. Publication year.
3. Type of publication.
4. Access information (DOI or URL).
5. Study design.
6. Location of the study (eg, country, region).
7. Description of the policy (eg, places covered, wheth-
er or not the intervention is implemented, national 
or regional/local implementation).
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a. Date of implementation.
b. Level of implementation (eg, government, munic-
ipality).
c. Level of enforcement (eg, voluntary, warnings, 
fines).
9. Observational period.
10. Selection of participants (eg, eligibility criteria, sam-
pling methods).
11. Number of participants.
12. Data source (eg, national survey, study recruited 
participants).
13. Method of data collection.
14. Definition of public support.
15. Statistical analyses (if applicable).
16. Number and percentages of missing values and non- 
response (if applicable).
17. Techniques for handling missing values and 
non- response.
18. Characteristics of the study population (eg, age, gen-
der, smoking status).
19. Levels of public support (estimate, 95% CIs).
20. Determinants of public support (see the Data synthe-
sis section for more detail).
a. Within- study determinants.
b. Between- study determinants.
c. Context- specific determinants.
21. Any conflict of interest reported by the authors.
22. Funding source(s).
Data will be complemented with the World Bank 
Country Classification by income, based on Gross National 
Income per capita.29 Furthermore, we will seek informa-
tion regarding whether at the time of the study tradi-
tional smoke- free regulation was already implemented in 
enclosed public areas and workspaces according to the 
WHO.23
Outcomes and prioritisation
Data will be extracted for each estimate of public support 
by the spaces that they cover (eg, playgrounds, private 
cars, multi- unit housing). If weighted and unweighted 
estimates are presented, we will extract estimates that are 
weighted to most adequately reflect the general popu-
lation. If multiple estimates are presented that relate to 
public support, we will extract the estimate that covers 
the most general spaces. For example, we will prioritise 
‘it should be illegal to smoke in all playgrounds’ above ‘it 
should be illegal to smoke in this specific playground’. If 
public support is asked in general and specifically related 
to children, we will extract both estimates. For example, 
we will extract ‘it should be illegal to smoke in private 
cars’ and ‘it should be illegal to smoke in private cars 
when minors are present’.
Risk of bias assessment
We will assess risk of bias for each study using the Mixed 
Methods Appraisal Tool (MMAT) for descriptive studies. 
The MMAT 2018 version was developed based on criteria 
from 18 existing critical appraisal tools and input from 
over 50 international experts. The following five elements 
will be assessed: relevance of the sampling strategy, repre-
sentativeness of the target population, appropriateness 
of the outcome measurements, risk of non- response bias 
and appropriateness of the statistical techniques. Each of 
the elements will be categorised by using the answer cate-
gories yes, no or can’t tell, following MMAT criteria. Results 
of the risk- of- bias analysis will be presented in tables.30
Data synthesis
Obtaining comparable data is essential to facilitate meta- 
analysis, thus homogenisation of the outcome data is 
needed. Public support will be analysed as proportional 
data, that is, proportion of the population supporting 
a particular smoke- free policy. When results are fairly 
normally distributed the raw proportions will be analysed, 
if not logit transformations will be applied.31 The outcome 
estimates will be reversed if studies report on the propor-
tion not in favour of the smoke- free policies. Often Likert 
scale- type questions are used to assess support; if studies 
report percentages per answer option instead of total 
support, the answer categories above neutral (ie, indi-
cating a positive response) will be combined.
To allow meta- analyses, SEs are needed. If SEs are not 
presented, they will be calculated using the following 
formula32 :
 fraction =
nr of people supporting policy








sample size  
Two reviewers will independently assess whether meas-
ures of public support and smoke- free policies under 
investigation are sufficiently comparable across the 
selected studies to allow meta- analysis. If needed, they 
will convert the units of measurement in a way that is 
consistent across studies. In case of disagreement, a third 
reviewer will decide which measures to use.
Prior to undertaking meta- analyses, we will subdi-
vide policies by spaces that they cover according to the 
following division: (1) indoor private spaces (eg, cars), (2) 
indoor semiprivate spaces (eg, multi- unit housing), (3) 
outdoor (semi)private spaces (eg, courtyard, psychiatric 
hospital), (4) non- hospitality outdoor public spaces (eg, 
parks, streets, beaches, hospital grounds, playgrounds) 
and (5) hospitality outdoor public spaces (eg, restaurant 
terraces). Separate meta- analyses will be conducted to 
assess public support for smoke- free policies according to 
these categories. If multiple estimates of public support 
are presented that cover similar spaces according to 
our categorisation, we will calculate the average public 
support across these spaces for use in meta- analyses. Thus, 
if studies present separate estimates of public support for 
playgrounds, parks and beaches (all belonging to the 
category ‘non- hospitality outdoor public spaces’), the 
average of the three will be used. In case of overlapping 
study samples, we will include the study or effect estima-
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to be representative of the general population, (2) has the 
lowest risk of bias or (3) incorporates the largest sample 
size, following this hierarchy. We aim to summarise the 
most up- to- date status of public support for novel smoke- 
free policies; thus, we will include the most recent esti-
mation if studies presented multiple estimates over time. 
In secondary analyses, we will evaluate whether public 
support changed following the actual introduction of the 
smoke- free policy under study, if the data allow.
One of the assumptions in meta- analysis is that effect 
sizes are independent, that is, the effect size of one study 
does not imply the direction or magnitude of the effect 
size in another study.33 Multiple estimates of public 
support in a specific country may violate the indepen-
dence assumption, therefore we will conduct a three- level 
meta- analysis.34 A three- level meta- analysis is an extended 
version of a random- effects meta- analysis and includes 
sampling variation at the first level, within- country 
heterogeneity at the second level and between- country 
heterogeneity at the third level. The analytical model is 
as follows:




ij + ζ(3)j + ϵij   .
Where  θ̂ij  is the estimation of the true effect size for public 




ij  is the within- 




j  is the between- country variance and  ϵij   
the sampling variance.34 In each model, heterogeneity will 
be quantified by the I² statistic per level. We intend to use 
R V.3.6.5 (R Foundation for Statistical Computing, 2020) 
using the packages meta and metaphor for all analyses.35 36 
A second analysis will be performed on all studies presenting 
the change in public support following implementation 
of the actual policy under study. If relevant analyses will be 
performed twice, once including estimates for public support 
in general and once for public support specifically related to 
children, for example, public support for smoking bans in 
cars and public support for smoking bans in cars if children 
are present (see the Outcomes and prioritisation section).
The secondary objective is to identify and quantify 
determinants that are associated with public support. The 
determinants of public support will be evaluated at three 
levels:
1. Quantify within- study determinants of public support.
Public support may differ between population subgroups. 
Therefore, we will conduct subgroup analyses according 
to:
 ► Gender (men vs women).
 ► Smoking status (current smokers vs former smokers 
vs non- smokers, and/or current smokers vs non- 
smokers (including former smokers), depending on 
data availability).
 ► Parental status (yes vs no, depending on data 
availability).
 ► Age group (younger vs older, categorisation 
depending on data availability).
Public support will be pooled per subgroup for each of 
the five spaces categories using random- effects three- level 
meta- analysis.37
2. Quantify between- study determinants of public support.
Various study- specific elements may influence public 
support. Random- effects linear meta- regression analysis 
will be performed to assess between- study determinants 
of public support according to the various spaces that 
the policies cover. In these analyses support in favour of 
smoke- free policies is used as dependent variable and the 
following variables per study are used as independent 
variables:
 ► Calendar year in which the survey was conducted 
(continuous).
 ► Whether public support was assessed as yes–no or on 
a Likert scale (binary).
 ► Income level of the country, according to the World 
Bank classification (binary: high- income vs low- 
income and middle- income countries).
 ► Whether or not traditional smoke- free legislation 
covering enclosed public places and workplaces was 
in place (categorical: none, partial or comprehensive 
according to the WHO classification).23
3. Identify context- specific determinants of public 
support.
Context- specific determinants of public support will 
be identified using thematic synthesis. We will follow the 
method outlined by Thomas and Harden consisting of 
three steps38 : (1) coding text, (2) developing descriptive 
themes and (3) generating analytical themes. The full text 
of each study will be extracted and uploaded into NVivo 
V.12 (NVivo Qualitative data analysis software V.10: QSR 
International, 2012). As studies may provide information 
outside the scope of this review, coding will be limited to 
sentences describing details that relate to determinants 
of public support for smoke- free policies. In order to 
ensure a consistent coding methodology, three eligible 
articles will be coded independently by two reviewers 
and then compared until consensus on the themes has 
been reached. The remaining articles will be coded 
independently by two reviewers. After every five articles, 
coding will be compared to ensure consistency. A priori 
four core domains have been identified: (1) beliefs and 
scientific evidence about effectiveness, (2) social norms, 
(3) communication and implementation strategies, and 
(4) collaboration between stakeholders.
Sensitivity analysis
Study findings may vary according to the risk- of- bias level of 
the individual studies. As a sensitivity analysis, we will exclude 
studies that scored no or can’t tell on at least one domain 
following the MMAT criteria. This criterion is based on 
MMAT evaluations in previous literature.39
Ethics and dissemination
No primary data collection will be undertaken; there-
fore, no formal ethical assessment and informed consent 
are required. Findings will be summarised in a single 
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